BIODESIX INC
Datakwaliteit: 100%
BDSX
Nasdaq
Services
Health Services
€ 12,90
▼
€ 1,35
(-9,47%)
Marktkapitalisatie: 127,17 M
Prijs
€ 12,90
Marktkapitalisatie
127,17 M
Dagbereik
€ 12,88 — € 14,37
52-Weeksbereik
€ 3,44 — € 20,21
Volume
36.703
Openen € 14,07
50D / 200D Gem.
€ 13,84
6,76% below
50D / 200D Gem.
€ 9,04
42,69% above
Quick Summary
Belangrijkste Punten
Revenue grew 12,88% annually over 5 years — strong growth
Negative free cash flow of -23,53 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 11,20%
Capital efficient — spends only 0,29% of revenue on capex
Groei
Revenue Growth (5Y)
12,88%
Boven sectorgemiddelde (3,99%)
Revenue (1Y)24,08%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
N/A
ROIC-30,76%
Net Margin-39,85%
Op. Margin-31,50%
Veiligheid
Debt / Equity
N/A
Current Ratio1,84
Interest Coverage-3,61
Waardering
PE (TTM)
-3,61
Onder sectorgemiddelde (-1,17)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Services sector mediaan (502 peers)
Sectorvergelijking
vs Services sector mediaan (502 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -3,6 | -1,2 |
| P/B | — | 1,4 |
| ROE % | — | -16,0 |
| Net Margin % | -39,9 | -19,4 |
| Rev Growth 5Y % | 12,9 | 4,0 |
| D/E | — | 0,4 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 24,08% | Revenue Growth (3Y) | 34,27% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 12,88% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 88,50 M | Net Income (TTM) | -35,27 M |
| ROE | N/A | ROA | -39,97% |
| Gross Margin | N/A | Operating Margin | -31,50% |
| Net Margin | -39,85% | Free Cash Flow (TTM) | -23,53 M |
| ROIC | -30,76% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 1,84 |
| Interest Coverage | -3,61 | Asset Turnover | 1,00 |
| Working Capital | 15,25 M | Tangible Book Value | -21,13 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -3,61 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | 1,44 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -18,50% | ||
| Market Cap | 127,17 M | Enterprise Value | 160,58 M |
| Per Share | |||
| EPS (Diluted TTM) | -4,67 | Revenue / Share | 8,98 |
| FCF / Share | -2,39 | OCF / Share | -2,36 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 0,29% | FCF Conversion | 66,72% |
| SBC-Adj. FCF | -28,11 M | Growth Momentum | 11,20 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 88,50 M | 71,32 M | 49,09 M | 38,21 M | 54,51 M |
| Net Income | -35,27 M | -42,93 M | -52,15 M | -65,45 M | -43,16 M |
| EPS (Diluted) | -4,67 | -0,33 | -0,64 | -1,55 | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -27,87 M | -34,50 M | -41,34 M | -50,59 M | -40,94 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 12,00 M | 9,56 M | 9,99 M | 13,10 M | 12,79 M |
| SG&A Expenses | 87,55 M | 80,45 M | 67,39 M | 61,46 M | 50,52 M |
| D&A | 5,67 M | 5,77 M | 3,33 M | 3,60 M | 3,18 M |
| Interest Expense | 7,72 M | 8,26 M | 9,54 M | 8,07 M | 4,51 M |
| Income Tax | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 87,48 M | 97,24 M | 99,10 M | 92,91 M | 76,10 M |
| Total Liabilities | 89,94 M | 76,37 M | 94,52 M | 72,30 M | 56,37 M |
| Shareholders' Equity | -2,47 M | 20,88 M | 4,58 M | 20,61 M | 19,73 M |
| Total Debt | 50,01 M | 40,03 M | 40,08 M | 30,13 M | 10,08 M |
| Cash & Equivalents | 18,99 M | 26,25 M | 26,28 M | 43,09 M | 32,71 M |
| Current Assets | 32,52 M | 39,48 M | 39,68 M | 53,33 M | 43,61 M |
| Current Liabilities | 17,44 M | 14,32 M | 33,42 M | 22,84 M | 28,96 M |
{"event":"ticker_viewed","properties":{"ticker":"BDSX","listing_kind":"stock","pathname":"/stocks/bdsx","exchange":"Nasdaq","country":"US"}}